Abstract
Multiple Sclerosis (MS) disease and its related syndromes are initiated by a neurodegenerative process that occurs in the central nervous system with some autoimmunity component. The patients with MS syndrome lose their productivity because of long-term morbidity and need for special assistance in daily activities as well as the need for immunomodulatory treatments and multidisciplinary health care. The remyelination process in the central nervous system due to MS requires proliferation and differentiation of oligodendrocyte precursor cells to generate mature oligodendrocytes that have a capacity for migration and myelin production in the defected area. Remyelination process requires functional mitochondria that can produce sufficient levels of ATP molecules. This method requires high oxygen levels and therefore it generates high levels of destructive reactive oxygen species (ROS) which should be eliminated. A growing body of evidence has shown the crucial role of mitochondrial uncoupling proteins (UCPs) in reducing the production of ROS that leads to a reduction in the harmful effects of oxidative stress and subsequently attenuates neurodegenerative pathology. This review provides an overview of the critical role of oligodendrocyte and mitochondria in the progression of multiple sclerosis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Pugliatti, M., Rosati, G., Carton, H., Riise, T., Drulovic, J., Ve’csei, L., and Milanov, I., Eur. Med. J., Neurol., 2006, vol. 13, pp. 700–722.
Koch-Henriksen, N. and Sorensen, P.S., Lancet, 2010, vol. 9, pp. 520–32.
Ebers, M., New York, Churchill Livingstone, 1998, pp. 191–221
Noseworthy, J.H., Lucchinetti, C., Rodriguez, M., and Weinshenker B.G., N. Engl. J. Med., 2000, vol. 343, pp. 938–952.
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H., Ann. Neurol., 2000, vol. 47, pp. 707–717.
Prat, A. and Antel, J., Curr. Opin. Neurol., 2005, vol. 18, pp. 225–230.
Frohman, E.M., Filippi, M., Stuve, O., Waxman, S.G., Corboy, J., Phillips, J.T., and Racke, M.K., Arch. Neurol., 2005, vol. 62, pp. 1345–1356.
Edgar, N. and Sibille, E., Transl. Psychiatry, 2012, vol. 2, pp. 1–9.
Nave K.A., Nature, 2010, vol. 468, pp. 244–252.
Rivers, L.E., Young, K.M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., and Richardson, W.D., Nat. Neurosci., 2008, vol. 11, pp. 1392–1401.
O’Meara, R.W., Michalski, J., and Kothary, R., J. Signal Transduction, 2011, vol. 2011, pp. 1–11.
Takebayashi, H., Nabeshima, Y., Yoshida, S., Chisaka, O., Ikenaka, K., and Nabeshima, Y., Curr. Biol., 2002, vol. 12, pp. 1157–1163.
Cai, J., Qi, Y., Hu, X., Tan, M., Liu, Z., Zhang, J., and Qiu, M., Neuron, 2005, vol. 45, pp. 41–53.
Fogarty, M., Richardson, W.D., and Kessaris, N., Development, 2005, vol. 132, pp. 1951–1959.
Kessaris, N., Fogarty, M., Iannarelli, P., Grist, M., Wegner, M., and Richardson, W.D., Nat. Neurosci, 2006, vol. 9, pp. 173–179.
Bradl, M. and Lassmann, H., Acta Neuropathol., 2010, vol. 119, pp. 37–53.
Miller R.H. and Mi, S., Nat. Neurosci., 2007, vol. 10, pp. 1351–1354.
Mi, S., Lee, X., Hu, Y., Ji, B., Shao, Z., Yang, W., Huang, G., Walus, L., Rhodes, K., Gong, J.G., Miller, R.H., and Pepinsky, B.R., Nat. Med., 2011, vol. 17, pp. 816–822.
Cavaliere, F., Urra, O., Alberdi, E., and Matute, C., Cell Death Dis., 2012, vol. 3, pp. 1–8.
Traka, M., Podojil, J.R., McCarthy, D.P., Miller, S.D., and Popko, B., Nat. Neurosci., 2016, vol. 19, pp. 65–74.
McTigue, D.M. and Tripathi, R.B., J. Neurochem., 2008, vol. 107, pp. 1–19.
Bauer, J., Bradl, M., Klein, M., Leisser, M., Deckwerth, T.L., Wekerle, H., and Lassmann, H., J. Neuropathol. Exp. Neurol., 2002, vol. 61, no. 1, pp. 12–22.
Connor, R.R. and Menzies, S.L., Glia, 1996, vol. 17, pp. 83–93.
Nave, K.A., Neuron, 2010, vol. 65, pp. 577–579.
Mahad, D.H., Trapp, B.D., and Lassmann, H., Lancet Neurol., 2015, vol. 14, pp. 183–193.
Trapp, B.D. and Stys, P.K., Lancet Neurol., 2009, vol. 8, pp. 280–291.
Campbell, G.R., Ziabreva, I., Reeve, A.K., Krishnan, K.J., Reynolds, R., Howell, O., Lassmann, H., Turnbull, D.M., and Mahad, D.J., Ann. Neurol., 2011, vol. 69, no. 3, pp. 481–492.
Kraytsberg, Y., Kudryavtseva, E., McKee, A.C., Geula, C., Kowall, N.W., and Khrapko, K., Nat. Genet., 2006, vol. 38, pp. 518–520.
Witte, M.E., Mahad, D.J., Lassmann, H., and van Horssen, J., Trends Mol. Med., 2014, vol. 20, pp. 179–187.
Krauss, S., Zhang, C.Y., and Lowell, B.B., Nat. Rev. Mol. Cell Biol., 2005, vol. 6, pp. 248–261.
Richard, D., Clavel, S., Huang, Q., Sanchis, D., and Ricquier, D., Soc. Trans., 2001, vol. 29, pp. 812–817.
Diano, S., Urbanski, H.F., Horvath, B., Bechmann, I., Kagiya, A., Nemeth, G., and Horvath, T.L., Endocrinology, 2000, vol. 141, pp. 4226–4238.
Mattiasson, M.P. and Liu, D., Biochem. Biophys. Res. Commun., 2003, vol. 304, pp. 539–549.
Andrews, Z.B., Horvath, B., Barnstable, C.J., Elsworth, J., Yang, L., Beal, M.F., Roth, R.H., Matthews, R.T., and Horvath, T.L., J. Neurosci., 2005, vol. 25, pp. 184–191.
Diano, S., Matthews, R.T., Patrylo, P., Yang, L., Beal, M.F., Barnstable, C.J., and Horvath, T.L., Endocrinology, 2003, vol. 144, pp. 5014–5021.
Huang, J.D., Chen, S.L., Lyu, J.J., Liu, C., and Zeng, Q.Y., Chin. J. Contemp. Pediatr., 2016, vol. 18, pp. 159–164.
Pheiffer, C., Jacobs, C., Patel, O., Ghoor, S., Muller, C., and Louw, J., J. Physiol. Biochem., 2016, vol. 72, pp. 25–32.
Korshunov, S.S., Skulachev, V.P., and Starkov, A.A., FEBS Lett., 1997, vol. 416, pp. 15–18.
Kudryavtseva, A.V., Krasnov, G.S., Dmitriev, A.A., Alekseev, B.Y., Kardymon, O.L., Sadritdinova, A.F., and Snezhkina, A.V., Oncotarget, 2016, vol. 7, pp. 44879–44905.
Nègre-Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R., Pénicaud, L., and Casteilla, L., FASEB J., 1997, vol. 11, pp. 809–815.
Kim-Han, J.S., Reichert, S.A., Quick, K.L., and Dugan, L.L., J. Neurochem., 2001, vol. 79, pp. 658–668.
Chan, S.L., Liu, D., Kyriazis, G.A., Bagsiyao, P., Ouyang, X., and Mattson, M.P., J. Biol. Chem., 2006, vol. 281, pp. 37391–37403.
Chu, A.C., Ho, P.W., Kwok, K.H., Ho, J.W., Chan, K.H., Liu, H.F., Kung, M.H., Ramsden, D.B., and Ho, S.L., Free Radical Biol. Med., 2009, vol. 46, pp. 810–820.
Kwok, K.H., Ho, P.W., Chu, A.C., Ho, J.W., Liu, H.F., Yiu, D.C., Chan, K.H., Kung, M.H., Ramsden, D.B., and Ho, S.L., Free Radical Biol. Med., 2010, vol. 49, pp. 1023–1035.
Szolnoki, Z., Curr. Med. Chem., 2010, vol. 17, pp. 3583–3590.
Sreedhar, A. and Zhao, Y., Mitochondrion, 2107, vol. 34, pp. 135–140.
Broadwater, L., Pandit, A., Clements, R., Azzam, S., Vadnal, J., Sulak, M., Yong, V.W., Freeman, E.J., Gregory, R.B., and McDonough, J., Biochim. Biophys. Acta, 2011, vol. 1812, no. 5, pp. 630–641.
Witte, M.E., Nijland, P.G., Drexhage, J.A., Gerritsen, W., Geerts, D., van Het Hof, B., Reijerkerk, A., de Vries, H.E., van der Valk, P., and van Horssen, J., Acta Neuropathol., 2013, vol. 125, pp. 231–243.
Slee, M., Finkemeyer, J., Krupa, M., Raghupathi, R., Gardner, J., Blumbergs, P., Agzarian, M., and Thyagarajan, D., J. Clin. Neurosci., 2011, vol. 18, pp. 1318–1324.
Larsson, N.G., Annu. Rev. Biochem., 2010, vol. 79, pp. 683–706.
Stys, P.K., Waxman, S.G., and Ransom, B.R., J. Neurosci., 1992, vol. 12, pp. 430–439.
Merzetti, E.M. and Staveley, B.E., Neurosci. Discov., 2013. 10.7243/2052-6946-1-8.
Dutta, R., McDonough, J., Yin, X., Peterson, J., Chang, A., Torres, T., Gudz, T., Macklin, W.B., Lewis, D.A., Fox, R.J., Rudick, R., Mirnics, K., and Trapp, B.D., Ann. Neurol., 2006, vol. 59, pp. 478–489.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is published in the original.
Rights and permissions
About this article
Cite this article
Rothan, H.A., Akram, S. An Overview on the Role of Oligodendrocytes and Mitochondria in the Progression of Multiple Sclerosis. Neurochem. J. 12, 205–209 (2018). https://doi.org/10.1134/S181971241803011X
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S181971241803011X